[script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js?client=ca-pub-6169568552679962" crossorigin="anonymous"][/script]

Tag: CRISPR

Business

WeRide, CRISPR And GeneDx Are Amongst Prime 10 Mid-Cap Gainers Final Week (Feb 10-Feb 14): Are The Others In Your Portfolio? – GeneDx Hldgs (NASDAQ:WGS), CRISPR Therapeutics (NASDAQ:CRSP), WeRide (NASDAQ:WRD)

February 16, 2025
admin

These ten mid-cap shares have been the perfect performers within the final week. Are they in…